Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
Cognitive therapy for depression.

British medical journal (Clinical research ed.)

Goldberg D.
PMID: 6799073
Br Med J (Clin Res Ed). 1982 Jan 16;284(6310):143-4. doi: 10.1136/bmj.284.6310.143.

No abstract available.

Psychopharmacology in children.

The New England journal of medicine

Brumback RA, Staton RD, Wilson H.
PMID: 6749202
N Engl J Med. 1984 Aug 16;311(7):473-4.

No abstract available.

Neuroanatomical circuits in depression: implications for treatment mechanisms.

Psychopharmacology bulletin

Drevets WC, Raichle ME.
PMID: 1480730
Psychopharmacol Bull. 1992;28(3):261-74.

We previously investigated the functional neuroanatomy of familial pure depressive disease (FPDD) using positron emission tomography (PET) measurements of regional blood flow and obtained evidence that flow is increased in the left prefrontal cortex, amygdala, and medial thalamus and...

[From symptomatic stability to functional recovery in the pharmacological treatment of schizophrenia and unipolar depression].

Vertex (Buenos Aires, Argentina)

Wikinski S.
PMID: 20038986
Vertex. 2009 Sep-Oct;20(87):351-8.

This work summarizes the efficacy of pharmacotherapy in the chronic course of schizophrenia and unipolar depresion. It is aimed to answer three questions: does it cure these diseases? Does it exert any significant effect on the symptomatic presentation of...

Depression and coronary heart disease: a review for cardiologists.

Clinical cardiology

Carney RM, Freedland KE, Sheline YI, Weiss ES.
PMID: 9068903
Clin Cardiol. 1997 Mar;20(3):196-200. doi: 10.1002/clc.4960200304.
Free PMC Article

Major depression is a common comorbid condition in patients with coronary heart disease (CHD). Although mild emotional distress may be a normal reaction to myocardial infarction or other manifestations of CHD, major depression should not be considered a normal...

Informing the policy process: from efficacy to effectiveness data on pharmacotherapy.

Journal of consulting and clinical psychology

Wells KB, Sturm R.
PMID: 8803353
J Consult Clin Psychol. 1996 Aug;64(4):638-45. doi: 10.1037//0022-006x.64.4.638.

Health care delivery is rapidly changing, but are the right data available to inform the policy process? This article illustrates the use of observational data on quality and effectiveness of treatment for anticipating the consequences of alternative forms of...

[Drug therapy of mood disorders, with special reference to depressive disorders].

Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica

Kondo T.
PMID: 20455315
Seishin Shinkeigaku Zasshi. 2010;112(3):269-73.

No abstract available.

Treatment of depression.

Science (New York, N.Y.)

Anderson RL.
PMID: 3764413
Science. 1986 Oct 17;234(4774):261. doi: 10.1126/science.234.4774.261-b.

No abstract available.

Managing our depressed patients. Gold standards vs higher standards.

Archives of family medicine

Block MR.
PMID: 9755739
Arch Fam Med. 1998 Sep-Oct;7(5):462-4. doi: 10.1001/archfami.7.5.462.

No abstract available.

Endogenous depression: current classifications and new treatments.

Irish medical journal

McKeon P.
PMID: 8444593
Ir Med J. 1993 Jan;86(1):3.

No abstract available.

Depression: diagnosis and treatment. A guide for the primary care physician.

The Journal of the Florida Medical Association

Dublis AM, Dublis RA.
PMID: 7175481
J Fla Med Assoc. 1982 Nov;69(11):923-8.

No abstract available.

A brave new world in managing depression--or is it?.

Australian family physician

Boyce PM, Hickie I.
PMID: 8198480
Aust Fam Physician. 1994 Apr;23(4):627-32.

In recent years new pharmacological agents have become available for the treatment of depression encouraging many to opt for the biochemical theory as the cause of depression. This article looks at the pros and cons and whether there is...

Showing 1 to 12 of 12 entries